Inhibiton of RET and JAK2 Signals and Upregulation of VEGFR3 Phosphorylation in Vitro by Galectin-1 in Trophoblast Tumor Cells BeWo

Placenta

Volumn 30, Issue 12, 2009, Pages 1078-1082

  Fischer, I ^a   Schulze, S ^a   Kuhn, C ^a   Friese, K ^a   Walzel, H ^b   Markert, U R ^c   Jeschke, U ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

BeWo; Galectin; JAK2; RET; VEGFR3

Indexed keywords

ANTIBODY; GALECTIN 1; JANUS KINASE 2; PROTEIN RET; REAGENT; RET ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CELL STIMULATION; CHORIOCARCINOMA; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STAINING; TROPHOBLAST; UPREGULATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; GALECTIN 1; HUMANS; IMMUNOHISTOCHEMISTRY; JANUS KINASE 2; PHOSPHORYLATION; PROTEIN ARRAY ANALYSIS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TROPHOBLASTIC NEOPLASMS; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 70449637047     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.10.003     Document Type: Article

References (38)

1. Barondes S.H., Castronovo V., Cooper D.N., Cummings R.D., Drickamer K., Feizi T., Gitt M.A., Hirabayashi J., Hughes C., Kasai K., et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell 76 4 (1994) 597-598
2. Perillo N.L., Pace K.E., Seilhamer J.J., and Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature 378 6558 (1995) 736-739
3. Walzel H., Blach M., Hirabayashi J., Kasai K.I., and Brock J. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 10 2 (2000) 131-140
4. Hughes R.C. Galectins as modulators of cell adhesion. Biochimie 83 7 (2001) 667-676
5. Raz A., and Lotan R. Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 6 3 (1987) 433-452
6. Wells V., and Mallucci L. Identification of an autocrine negative growth factor: mouse beta-galactoside-binding protein is a cytostatic factor and cell growth regulator. Cell 64 1 (1991) 91-97
7. Adams L., Scott G.K., and Weinberg C.S. Biphasic modulation of cell growth by recombinant human galectin-1. Biochim Biophys Acta 1312 2 (1996) 137-144
8. Offner H., Celnik B., Bringman T.S., Casentini-Borocz D., Nedwin G.E., and Vandenbark A.A. Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol 28 2 (1990) 177-184
9. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., Toscano M.A., Bianco G.A., Kobelt P., Handjiski B., Tirado I., Markert U.R., Klapp B.F., Poirier F., Szekeres-Bartho J., Rabinovich G.A., and Arck P.C. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13 12 (2007) 1450-1457
10. Walzel H., Neels P., Bremer H., Kohler H., Raab N., Barten M., and Brock J. Immunohistochemical and glycohistochemical localization of the beta-galactoside-binding S-type lectin in human placenta. Acta Histochem 97 1 (1995) 33-42
11. Vicovac L., Jankovic M., and Cuperlovic M. Galectin-1 and -3 in cells of the first trimester placental bed. Hum Reprod 13 3 (1998) 730-735
12. Jeschke U., Mayr D., Schiessl B., Mylonas I., Schulze S., Kuhn C., Friese K., and Walzel H. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 28 11-12 (2007) 1165-1173
13. Richter D.U., Jeschke U., Makovitzky J., Goletz S., Karsten U., Briese V., and Friese K. Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta. Anticancer Res 20 6D (2000) 5129-5133
14. Jeschke U., Richter DU., Hammer A., Briese V., Friese K., and Karsten U. Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro. Histochem Cell Biol 117 3 (2002) 219-226
15. Jeschke U., Karsten U., Wiest I., Schulze S., Kuhn C., Friese K., and Walzel H. Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody. Histochem Cell Biol 126 4 (2006) 437-444
16. Daoud G., Amyot M., Rassart E., Masse A., Simoneau L., and Lafond J. ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. J Physiol 566 Pt 2 (2005) 409-423
17. Kita N., Mitsushita J., Ohira S., Takagi Y., Ashida T., Kanai M., Nikaido T., and Konishi I. Expression and activation of MAP kinases, ERK1/2, in the human villous trophoblasts. Placenta 24 2-3 (2003) 164-172
18. Fitzgerald J.S., Poehlmann TG., Schleussner E., and Markert UR. Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3). Hum Reprod Update 14 4 (2008) 335-344
19. Fitzgerald J.S., Tsareva S.A., Poehlmann T.G., Berod L., Meissner A., Corvinus F.M., Wiederanders B., Pfitzner E., Markert U.R., and Friedrich K. Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Int J Biochem Cell Biol 37 11 (2005) 2284-2296
20. Hunter T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci 353 1368 (1998) 583-605
21. Remmele W., and Stegner H.E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8 3 (1987) 138-140
22. Cohen M., and Bischof P. Factors regulating trophoblast invasion. Gynecol Obstet Invest 64 3 (2007) 126-130
23. Hirabayashi J., and Kasai K. Human placenta beta-galactoside-binding lectin. Purification and some properties. Biochem Biophys Res Commun 122 3 (1984) 938-944
24. van den Brule F., Califice S., Garnier F., Fernandez P.L., Berchuck A., and Castronovo V. Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Lab Invest 83 3 (2003) 377-386
25. Rabinovich G.A., Rubinstein N., Matar P., Rozados V., Gervasoni S., and Scharovsky G.O. The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression. Cancer Immunol Immunother 50 11 (2002) 597-603
26. Wiest I., Seliger C., Walzel H., Friese K., and Jeschke U. Induction of apoptosis in human breast cancer and trophoblast tumor cells by galectin-1. Anticancer Res 25 3A (2005) 1575-1580
27. Schiessl B., Innes B.A., Bulmer J.N., Otun H.A., Chadwick T.J., Robson S.C., and Lash G.E. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta 30 1 (2009) 79-87
28. Shibuya M., and Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312 5 (2006) 549-560
29. Pachnis V., Mankoo B., and Costantini F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119 4 (1993) 1005-1017
30. Treanor J.J., Goodman L., de Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., Gray C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., and Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature 382 6586 (1996) 80-83
31. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.C., Hu S., Altrock B.W., and Fox G.M. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85 7 (1996) 1113-1124
32. Baloh R.H., Tansey M.G., Golden J.P., Creedon D.J., Heuckeroth R.O., Keck C.L., Zimonjic D.B., Popescu N.C., Johnson Jr. E.M., and Milbrandt J. TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron 18 5 (1997) 793-802
33. Buj-Bello A., Adu J., Pinon L.G., Horton A., Thompson J., Rosenthal A., Chinchetru M., Buchman V.L., and Davies A.M. Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature 387 6634 (1997) 721-724
34. Fukuda T., Kiuchi K., and Takahashi M. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. J Biol Chem 277 21 (2002) 19114-19121
35. Schuringa J.J., Wojtachnio K., Hagens W., Vellenga E., Buys C.H., Hofstra R., and Kruijer W. MEN2A-RET-induced cellular transformation by activation of STAT3. Oncogene 20 38 (2001) 5350-5358
36. Chiariello M., Visconti R., Carlomagno F., Melillo R.M., Bucci C., de Franciscis V., Fox G.M., Jing S., Coso O.A., Gutkind J.S., Fusco A., and Santoro M. Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret. Oncogene 16 19 (1998) 2435-2445
37. Jhiang S.M. The RET proto-oncogene in human cancers. Oncogene 19 49 (2000) 5590-5597
38. Plaza Menacho I., Koster R., van der Sloot A.M., Quax W.J., Osinga J., van der Sluis T., Hollema H., Burzynski G.M., Gimm O., Buys C.H., Eggen B.J., and Hofstra R.M. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor. Cancer Res 65 5 (2005) 1729-1737